◆ 会议时间：2026年5月12-16日
◆ 会议地点：美国 波士顿

◆ 会议简介：

2026年第29届美国基因与细胞治疗学会(ASGCT)年会将于2026年5月12-16日在美国波士顿举行。ASGCT年会是全球基因和细胞治疗领域规模最大的学术会议，为与会者提供了一个介绍最新基因与细胞疗法的发展以及提出并进行批判性讨论的国际平台。作为全球领先的基因与细胞治疗学会议，ASGCT年会吸引了近3500名来自世界各地的专业人士与会，与会者包括科学家、医生、患者和支持者等等（2021年虚拟会议有近6800余名代表参与）。

美国基因与细胞治疗学会(ASGCT)成立于1996年，是全球最大的专业从事基因和细胞治疗研究的非赢利性医学组织，是世界基因与细胞治疗领域最具权威性与公信力的机构，在全球拥有超过2500名成员。ASGCT宣设有癌症治疗、心血管和遗传委员会等若干个科学委员会。未经许可禁止复制摘录转载本站任何内容-国际医学会议网（lingyuint.com）。

ASGCT 2026 - 29th Annual Meeting of the American Society of Gene & Cell Therapy

Date:　
May 12-16, 2026

Venue:
Boston Convention and Exhibition Center
Boston, USA

摘要征文投稿：

Abstract Submission Dates

点此查看更多摘要提交相关信息>>>

Abstract Types

• Oral Abstract Presentations
• Poster Presentations
• Poster Talks

Submission Guidelines

All abstracts must be submitted with the following criteria:

• Submitted and presented in English
• Sentence case titles with only italicized text, please remove bolded or underlined text
• No reference to institution affiliation in the body of the text
• Structured format: Introduction, Methods, Results, and Conclusion

All authors must be submitted with the following information:

• First Name
• Last Name
• Professional Credentials
• Current Email Address
• Institution Affiliation

Please note: authors should be submitted in the desired order.

ASGCT does not accept abstracts that are overly commercial or proprietary in nature.

Submission Requirements

• All abstracts are capped at 3,500 characters not including spaces.
• All abstracts must be submitted in clear and concise English. Spelling may be in U.S. English or UK English.
• Remove all track changes before submitting your abstract; these changes can be picked up with copy and paste functions, making the abstract incoherent.
• The title should be entered exactly as it is to appear online—titles should be submitted in sentence case, AMA formatting. You may use this text converter to help create the perfect title.
  • Here is an example of a sentence case abstract title: A multi-targeting, nucleoside-modified mRNA influenza virus vaccine provides broad protection in mice.
• The names, prefixes, email addresses, and institutional affiliations of all co-authors must be provided at the time of submission.
  • Any names excluded in the submission will not be listed in the author block of the publication.
  • Co-authors will also be asked to fill out their financial disclosures.
• It is the responsibility of the submitter to proofread the abstract and author list carefully. Abstracts will be published as submitted.
• Tables and figures may be uploaded via a photo file type, .jpeg, .jpg, or .png.
  • Each abstract is limited to two uploads.
  • Figures should be labeled with a number and/or caption as a footer.
• The abstract should be structured, i.e., divided into sections: introduction, methods, results, conclusions
• Do not use bold type or underline formatting—italic type is acceptable.
• Changes to abstract content and author block may be made by the submitter prior to the close of the submission deadline.
• Edit requests for submissions following the submission deadline are not guaranteed. No changes will be made after the withdrawal deadline.
• The presenting author of abstracts selected for Oral or Poster presentation must attend the event in person. If the original designated presenting author cannot attend, a co-author may be designated as an alternative presenter. Please submit presenting author changes to abstracts@asgct.org.

◆ 参会对象：医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。